Recent developments with Cerevel Therapeutics Holdings Inc (CERE) have led to the company’s beta value being reach 1.48 cents.
On Tuesday, Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) opened lower -0.09% from the last session, before settling in for the closing price of $42.75. Price